WeVote
Log In

Bill

Bill

SB 122

Relating to required labeling of certain products containing or derived from aborted human fetal tissue.

89th Legislature (2025) Introduced by Bob Hall

Texas bill requiring manufacturers to label products containing or derived from aborted human fetal tissue, affecting pharmaceuticals, vaccines, and cosmetics with compliance penalties.

Referred to Health & Human Services
#abortion(i0005) #health&humanservicescommission(v0177) #health--general(i0385) #packaging&labelingrequirements(s0339)
0
WeVote Research Nonpartisan
Bill Summary · SB 122

Legislative bill overview

SB 122 would require manufacturers to label products that contain or are derived from aborted human fetal tissue. The bill establishes labeling requirements for such products sold in Texas and specifies penalties for non-compliance. This represents an attempt to increase consumer disclosure regarding cell lines used in product development and testing.

Why is this important

This bill addresses consumer transparency concerns held by those who object to abortion on moral or religious grounds. It directly affects the commercial availability and marketing of pharmaceuticals, vaccines, and cosmetics that have utilized fetal cell lines in research, development, or testing—a common practice in modern medical product development. The practical impact depends on how broadly "derived from" is interpreted and enforced.

Potential points of contention

  • Scientific and medical feasibility: Many established medicines and vaccines use fetal cell lines from the 1970s-1980s in testing or manufacturing; compliance could be technically complex and costly, potentially affecting drug availability or pricing
  • Constitutional concerns: Mandatory speech requirements on products may face First Amendment challenges regarding compelled commercial speech
  • Scope and enforcement: The definition of what qualifies as "derived from" aborted fetal tissue is unclear—it could apply narrowly to direct use or broadly to any product ever tested using these cell lines, creating ambiguity and enforcement difficulties
  • Interstate commerce implications: Texas-only labeling requirements could create distribution challenges for national manufacturers

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.